LOCUS       ABV11391.1              1339 aa    PRT              BCT 31-JAN-2014
DEFINITION  Citrobacter koseri ATCC BAA-895 hypothetical protein protein.
ACCESSION   CP000822-213
PROTEIN_ID  ABV11391.1
SOURCE      Citrobacter koseri ATCC BAA-895
  ORGANISM  Citrobacter koseri ATCC BAA-895
            Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
            Enterobacteriaceae; Citrobacter.
REFERENCE   1  (bases 1 to 4720462)
  AUTHORS   McClelland,M., Sanderson,E.K., Porwollik,S., Spieth,J.,
            Clifton,W.S., Latreille,P., Courtney,L., Wang,C., Pepin,K.,
            Bhonagiri,V., Nash,W., Johnson,M., Thiruvilangam,P. and Wilson,R.
  CONSRTM   The Citrobacter koseri Genome Sequencing Project
  TITLE     Direct Submission
  JOURNAL   Submitted (29-AUG-2007) Genetics, Genome Sequencing Center, 4444
            Forest Park Parkway, St. Louis, MO 63108, USA
COMMENT     Citrobacter (diversus) koseri--Citrobacter cells are isolated from
            water, sewage, soils, and food, as well as from the feces of man
            and other animals, where they may be normal inhabitants. They can
            be found in urine, sputum, and other clinical specimens. They can
            sometimes be opportunistic pathogens particularly in
            immunocompromised patients in hospitals or in infants (Pepperell et
            al., Antimicrob Agents Chemother. 2002 Nov;46(11):3555-60. and
            references therein).
            
            The strain of Citrobacter koseri being sequenced, strain CDC
            4225-83, was isolated in 1983 in Maryland, where it caused neonatal
            meningitis. It was provided by Caroline Mohr and Melissa Campbell
            of CDC. The strain is available from the American Type Culture
            Collection as ATCC BAA-895 or from the Salmonella Genetic Stock
            Centre as SGSC4696. The genome was sequenced to 8X coverage, using
            plasmid and fosmid libraries and was finished to an error rate of
            less than 1 per 10,000 bases. Automated annotation was performed
            and manual annotation will continue in the labs of Michael
            McClelland and Kenneth Sanderson. The National Institute of Allergy
            and Infectious Diseases (NIAID), National Institutes of Health
            (NIH) has funded this project.
            
            Coding sequences below are predicted using GeneMark v3.3 and
            Glimmer2 v2.13.Intergenic regions not spanned by GeneMark and
            Glimmer2 were blasted against NCBI's non-redundant (NR) database
            and predictions generated based on protein alignments. RNA genes
            were determined usingtRNAscan-SE 1.23 or Rfam v8.0. This sequence
            was finished as follows unless otherwise noted: all regions were
            double stranded, sequenced with an alternate chemistries or covered
            by high quality data (i.e., phred quality >=30); an attempt was
            made to resolve all sequencing problems, such as compressions and
            repeats; all regions were covered by sequence from more than one
            m13 subclone.
FEATURES             Qualifiers
     source          /organism="Citrobacter koseri ATCC BAA-895"
                     /mol_type="genomic DNA"
                     /strain="ATCC BAA-895"
                     /db_xref="ATCC:BAA-895"
                     /db_xref="taxon:290338"
     protein         /locus_tag="CKO_00226"
                     /inference="protein motif:HMMPfam:IPR000728"
                     /inference="protein motif:HMMPfam:IPR010918"
                     /inference="protein motif:HMMTigr:IPR010073"
                     /note="KEGG: eci:UTI89_C2877 0. purL;
                     phosphoribosylformyl-glycineamide synthetase K01952; COG:
                     COG0046 Phosphoribosylformylglycinamidine (FGAM) synthase,
                     synthetase domain"
                     /transl_table=11
                     /db_xref="InterPro:IPR000728"
                     /db_xref="InterPro:IPR010073"
                     /db_xref="InterPro:IPR010918"
BEGIN
        1 MIRKGGDFIS TQTVSSGRQI LYNVARFPPC AHLKRLRRFE DERLMMEILR GSPALSAFRI
       61 NKLLARFQAA NLQVHNIYAE YVHFADLSAP LNEDEHAQLA RLLKYGPSLS SHTPEGKLLL
      121 VTPRPGTISP WSSKATDIAH NCGLQQVSRL ERGVAYYVEA ATLTAEQWQT IAAELHDRMM
      181 ETVFSSLSDA EKLFVHHQPA PVASVDLLGE GRQALTDANL RLGLALADDE IDYLQDAFTK
      241 LGRNPNDIEL YMFAQANSEH CRHKIFNADW VIDGKPQPKS LFKMIKNTFE TTPDHVLSAY
      301 KDNAAVMEGS DVGRYFADHE SGRYDFHQEP AHILMKVETH NHPTAISPWP GAATGSGGEI
      361 RDEGATGRGA KPKAGLVGFS VSNLRIPGFE QPWEEDFGKP ERIVTALDIM TEGPLGGAAF
      421 NNEFGRPALN GYFRTYEEKV NSHNGEELRG YHKPIMLAGG IGNIRADHVQ KGEIVVGAKL
      481 IVLGGPAMNI GLGGGAASSM ASGQSDADLD FASVQRDNPE MERRCQEVID RCWQLGDANP
      541 ILFIHDVGAG GLSNAMPELV SDGGRGGKFE LRDILSDEPG MSPLEIWCNE SQERYVLAVA
      601 ADQLPLFDEL CKRERAPYAV IGEATEEQHL SLNDSHFDNQ PIDLPLDVLL GKTPKMTRDV
      661 QTLTAKGDAL DRADITIADA VKRVLHLPTV AEKTFLVTIG DRTVTGMVAR DQMVGPWQVP
      721 VANCAVTTAS LDSYYGEAMS IGERAPVALL DFAASARLAV GEALTNIAAT QIGDIKRIKL
      781 SANWMAAAGH PGEDAGLYDA VKAVGEELCP QLGLTIPVGK DSMSMKTRWQ EGNEQREMTS
      841 PLSLVISAFA RVEDVRHTVT PQLSTEDNAL LLIDLGQGHN ALGATALAQV YRQLGDKPAD
      901 VRDVAQLKGF YDAIQALVAQ RKLLAYHDRS DGGLLVTLAE MAFTGHCGIQ VDIATSGDDR
      961 LAALFNEELG AVIQVRAADR EAVEALLAKH GLSDCVHYLG QAVSGDRFVI ESNGQVVFSE
     1021 SRTTLRTWWA ETTWQMQRLR DNPECADQEH DAKTNDADPG LNVKLSFDIN EDIAAPYIAT
     1081 GARPKVAVLR EQGVNSHVEM AAAFHRAGFD AIDVHMSDLL AGRIGLGNFQ ALVACGGFSY
     1141 GDVLGAGEGW AKSILFNNRV RDEFETFFHR PQTLALGVCN GCQMMSNLRE LIPGSELWPR
     1201 FVRNHSDRFE ARFSLVEVTQ SPSLLLQGMV GSQMPVAVSH GEGRVEVRDD AHLAGLESKG
     1261 LVALRYVDNF GKVTENYPAN PNGSPNGITA VTTENGRATI MMPHPERVFR TVSNSWHPEN
     1321 WGEDSPWMRI FRNARKQLG
//